US Patent Issued to Takeda Pharmaceutical on April 29 for "Isofagomine salts, methods of use and formulations" (American, French, Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,400, issued on April 29, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Isofagomine salts, methods of use and formulations" was invented by Helge Reisch (Westerly, R.I.), Jeffrey Scott Depue (Windham, N.H.), Fritz Blatter (Reinach BL, Switzerland), Jennifer Robin (Waldighoffen, France), Michael Peter Hahn (Lexington, Mass.), Gaozhong Zhu (Weston, Mass.) and Muthuraman Meiyappan (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to the field of pharmaceuticals, and specifically relates to isofagomine (IFG), novel salts thereof and preparation methods and uses of these, for example,...